Dr. Alexander Landfield
Board-Certified Neurologist & Medical Director
One of the most frequently asked questions at Rani Beauty Clinic in Renton, WA, is whether patients can drink alcohol while taking GLP-1 medications like semaglutide or tirzepatide. The short answer is that moderate alcohol consumption is not strictly prohibited, but there are important considerations every patient should understand.
GLP-1 medications slow gastric emptying, and alcohol is no exception. When alcohol lingers in the stomach longer, absorption patterns change, and many patients report feeling the effects of alcohol more quickly and intensely than before starting treatment. This altered tolerance means that a glass of wine that previously had minimal effect may now produce noticeable intoxication. Patients should approach alcohol cautiously, especially during the first few months of treatment, and never drive after drinking until they understand their new tolerance.
From a weight-loss perspective, alcohol is a significant source of empty calories. A standard glass of wine contains roughly 120 to 150 calories, a beer ranges from 100 to 200 calories, and cocktails with mixers can exceed 300 calories. Given that semaglutide and tirzepatide reduce total caloric intake by suppressing appetite, spending a meaningful portion of those reduced calories on alcohol can substantially slow weight-loss progress. Alcohol also impairs judgment around food choices, making late-night snacking more likely.
Alcohol can also worsen the gastrointestinal side effects associated with GLP-1 medications. Nausea, acid reflux, and stomach discomfort may be intensified after drinking. Dr. Landfield advises patients to limit alcohol to one to two drinks per occasion, choose lower-calorie options like dry wine or light beer, avoid sugary cocktails entirely, and stay well-hydrated before and after drinking. If you find that alcohol consistently causes discomfort, abstaining during the active weight-loss phase will yield the best results.
